Nothing Special   »   [go: up one dir, main page]

Peracchia et al., 1998 - Google Patents

Pegylated nanoparticles from a novel methoxypolyethylene glycol cyanoacrylate-hexadecyl cyanoacrylate amphiphilic copolymer

Peracchia et al., 1998

Document ID
17999990676041728087
Author
Peracchia M
Vauthier C
Desmaële D
Gulik A
Dedieu J
Demoy M
d'Angelo J
Couvreur P
Publication year
Publication venue
Pharmaceutical research

External Links

Snippet

Purpose. The aim of this work was to develop PEGylated poly (alkylcyanoacrylate) nanoparticles from a novel methoxypolyethyleneglycol cyanoacrylate-co-hexadecyl cyanoacrylate copolymer. Methods. PEGylated and non-PEGylated nanoparticles were …
Continue reading at link.springer.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
    • A61K47/48876—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being a solid micro- or nanoparticle having no hollow or gas-filled core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48169—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule

Similar Documents

Publication Publication Date Title
Peracchia et al. Pegylated nanoparticles from a novel methoxypolyethylene glycol cyanoacrylate-hexadecyl cyanoacrylate amphiphilic copolymer
Coombes et al. Biodegradable polymeric microparticles for drug delivery and vaccine formulation: the surface attachment of hydrophilic species using the concept of poly (ethylene glycol) anchoring segments
Howard et al. PEGylation of nanocarrier drug delivery systems: state of the art
Li et al. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats
Peracchia et al. Stealth® PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting
Araujo et al. Influence of the surfactant concentration on the body distribution of nanoparticles
US7541017B2 (en) Amine polymer-modified nanoparticulate carriers
CA2167921C (en) Biodegradable particles
JP3887454B2 (en) Method for producing polymer hydrophilic nanoparticles
Bhardwaj et al. Pharmaceutical aspects of polymeric nanoparticles for oral drug delivery
US20080241266A1 (en) Amine polymer-modified nanoparticulate carriers
AU2012251971B2 (en) Polymeric nanoparticles for drug delivery
SG173455A1 (en) Hollow silica particle with a polymer thereon
HUT75469A (en) Drug targeting system, method for preparing same and its use
Jin et al. Chitosan–glutathione conjugate-coated poly (butyl cyanoacrylate) nanoparticles: promising carriers for oral thymopentin delivery
Wang et al. The effects of poly (zwitterions) s versus poly (ethylene glycol) surface coatings on the biodistribution of protein nanoparticles
Shi et al. Hemoglobin conjugated micelles based on triblock biodegradable polymers as artificial oxygen carriers
Ning et al. Carboxymethyl dextran-coated liposomes: Toward a robust drug delivery platform
Kamei et al. Prolonged blood circulation in rats of nanospheres surface-modified with semitelechelic poly [N-(2-hydroxypropyl) methacrylamide]
EP1876188A1 (en) Two step miniemulsion process
US20050043481A1 (en) Material consisting of at least a biodegradable polymer and cyclodextrins
Licciardi et al. Polyaspartamide‐graft‐Polymethacrylate Nanoparticles for Doxorubicin Delivery
Liang et al. 5-Fluorouracil-loaded self-assembled pH-sensitive nanoparticles as novel drug carrier for treatment of malignant tumors
Ray et al. Synthesis and colon-specific drug delivery of a poly (acrylic acid-co-acrylamide)/MBA nanosized hydrogel
Nguyen et al. Synthesis of a novel fluorescent poly (D, L-lactide) end-capped with 1-pyrenebutanol used for the preparation of nanoparticles